Biomaterials Group

The Biomaterials Group portfolio includes mammalian cell measurements, microbial cell measurements, biomaterials and cell-material interactions, and advanced imaging and spectroscopy.  These efforts bolster the development and translation of regenerative medicine and advanced protein-, cell-, and microbe-based therapeutics in support of the bioeconomy.

Projects and programs

• Mammalian Cell Measurements: Quantification and characterization of mammalian cell and cell system properties in support of the generation, translation, and biomanufacturing of cell therapy and regenerative medicine products.   
  • Cell Counting for Cell Therapies
  • Cell Viability for Advanced Therapies
  • Measuring Cell Viability in Scaffolds
  • Biomanufactured Retinal Pigment Epithelium

• Microbial Measurements: Methods, technologies, and standards to quantify microbial cells and complex microbial communities to address critical measurement needs in industry and biodefense.   
  • Microbial Cell Quantification
  • Microbial Viability 
  • Standards for Biothreat Detection

• Biomaterials & Cell-Material Interactions: Quantitative measurements of biomaterial properties and the biological and microbial response to biomaterials to advance regenerative medicine and medical device technologies.  
  • Approaches to Control Biofilm Structure
  • 3D Cell-Scaffold Interactions  
  • Photopolymerized Biomaterials 
  • Fiber Scaffold Characterization 
• Advanced Imaging & Spectroscopy: Novel spectral, imaging, and quantum methods to characterize and quantify molecular content of biological systems and materials.   
  • Label-Free Chemical Imaging
  • High-Sensitivity Spectroscopy
  • Quantum Bioimaging 
  • 3D Molecular Orientation Imaging